NCT05972577View on ClinicalTrials.gov

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic AnemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell NeoplasmHodgkin LymphomaMyelodysplastic SyndromeMyelofibrosisMyeloproliferative NeoplasmNon-Hodgkin LymphomaPlasma Cell Myeloma
Interventions
OTHER

Health Promotion and Education

Undergo GO!

OTHER

Medical Device Usage and Evaluation

Wear accelerometer

OTHER

Quality-of-Life Assessment

Complete quality of life assessments and diary entries

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER